EHS
EHS

What Pfizer, Trump, and consumers got out of a surprising deal — and what they didn’t

WASHINGTON — After months of pledging he would get pharmaceutical companies to lower their prices, President Trump can now say that he pressed the CEO of a major drug maker, Pfizer, to back down on a series of price hikes.

Pfizer, in turn, has earned glowing praise from Trump and his administration and will likely not suffer much, if at all, financially.

Read the rest…

EHS

Leave a Reply

Your email address will not be published.

Back to top button